WRM
TEVA icon

Westport Resources Management’s Teva Pharmaceuticals TEVA Stock Holding History

Westport Resources Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,500
Closed -$79K – 1109
2014
Q1 		$79K Buy
+1,500
New +$69.3K 0.02% 473

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Westport Resources Management's TEVA Position: Q3 2016 in Review

Westport Resources Management reduced its Teva Pharmaceuticals (TEVA) stake by 17% in Q3 2016, selling an estimated $48.8K and leaving 4,500 shares worth $207K. The position accounts for 0.15% of the portfolio, ranked #141.

Westport Resources Management first reported a position in TEVA in Q2 2013 and has held it in 14 quarters since. The position peaked at $507K in Q1 2014. 795 funds tracked by Wall St. Rank hold TEVA as of Q3 2016.

  • Westport Resources Management held 4,500 shares of Teva Pharmaceuticals worth $207K as of Q3 2016.
  • Westport Resources Management sold 935 Teva Pharmaceuticals shares in Q3 2016, an estimated $48.8K.
  • Teva Pharmaceuticals made up 0.15% of Westport Resources Management's portfolio in Q3 2016, its #141 holding.
  • Westport Resources Management first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 14 quarters since.
  • Westport Resources Management's Teva Pharmaceuticals position peaked at $507K in Q1 2014.
  • 795 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2016.

Based on Westport Resources Management's 13F filing for Q3 2016, filed 14 Nov 2016.